Skip to main content
Log in

ACE inhibitors + insulin secretagogues = serious hypoglycaemia?

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Nam YH, et al. Angiotensin-Converting Enzyme Inhibitors Used Concomitantly with Insulin Secretagogues and the Risk of Serious Hypoglycemia. Clinical Pharmacology and Therapeutics : 27 Jul 2021. Available from: URL: http://doi.org/10.1002/cpt.2377

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ACE inhibitors + insulin secretagogues = serious hypoglycaemia?. Reactions Weekly 1868, 4 (2021). https://doi.org/10.1007/s40278-021-00461-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-00461-8

Navigation